Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-017838
Filing Date
2023-08-08
Accepted
2023-08-08 16:05:07
Documents
2
Period of Report
2023-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1587
2 EX-24 DOCUMENT attachment1.htm EX-24 3444
  Complete submission text file 0000899243-23-017838.txt   6392
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Issuer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RANI THERAPEUTICS HOLDINGS, INC. 2051 RINGWOOD AVE. SAN JOSE CA 95131
Business Address
McKinley Kate (Reporting) CIK: 0001979211 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40672 | Film No.: 231151154